A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma
Clinical trial NCT00417677 · TERMINATED
Trial details
- NCT number
- NCT00417677
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.